WHO ICTRP trial

A comparison of the effects of insulin Detemir with insulin Glargine on weight…

EUCTR2007-004144-74-GB · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2007-004144-74-GB
Public title A comparison of the effects of insulin Detemir with insulin Glargine on weight gain in female adolescents and young adults with Type 1 Diabetes (T1D) on a basal bolus regime - A comparison of Insulins Detemir and Glargine in Girls with Diabetes
Scientific title A comparison of the effects of insulin Detemir with insulin Glargine on weight gain in female adolescents and young adults with Type 1 Diabetes (T1D) on a basal bolus regime - A comparison of Insulins Detemir and Glargine in Girls with Diabetes
Primary sponsor Cambridge University Hospitals NHS Foundation Trust
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes
Countries United Kingdom
Conditions Type 1 diabetes MedDRA version: 9.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus
Interventions Trade Name: Levemir Flexpen Pharmaceutical Form: Injection* Trade Name: Lantus 100 U/ml OptiSet solution for injection Pharmaceutical Form: Injection* Trade Name: Lantus 100u/ml solution for injection in Solostar prefilled pen…
Registration date Oct 15, 2007
Target size 125
Secondary IDs DG07
Registry page clinicaltrialsregister.eu

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations